RNA Analytical/Quality Videos
-
Engaging Early In Process Development To Bring mRNA Sequences To Life
Examine why template sequence characteristics are relevant for cGMP manufacturing of high-quality mRNA and consider insights on how to develop a scalable, robust, and economically viable process.
-
Validation Of mRNA Concentration Determination
8/20/2023
mRNA-based therapeutics require comprehensive analytical testing to meet regulatory requirements. Optimize processes and ensure fast and reliable results as you bring your product to market.
-
Crafting A "Durable" Partnership: A Two-Pronged Approach
Featured speakers for the "Got Raw Materials? The State Of The mRNA Supply Chain" event share how they are working to deepen their partnerships today.
-
Optimize DNA Storage Using Dedicated Fluoropolymer Film
5/9/2023
Discover how to integrate appropriate materials and tools for oligonucleotide handling, optimize DNA storage using dedicated fluoropolymer film, perform complex biochemical reactions in bags, and more.
-
What Does 2025 (And Beyond) Hold For The RNA-LNP Space?
12/4/2024
Three LNP experts share their thoughts on the incremental advancements they’d like to see the RNA-LNP space make in the next few years.
-
Quantifying Cell Response With Duplex RT-qPCR
Discover a new potency bioassay using RT-qPCR to assess relative transcription activity, and learn more about the advantages and limitations of transcriptional assays versus reporter gene assays.
-
Is QbD Actually Possible In mRNA Development Today?
8/22/2024
As the panelists of this Advancing RNA LIVE discussion argue, there are several big limitations we face in implementing QBD today for RNA development.
-
LBA Vs. LC-MS: Competing Technologies At A Development Crossroad
2/6/2025
Watch as bioanalytical experts Shane Karnik, MS, and Matt Hartle, Ph.D., explore why many sponsors are reevaluating the use of LBA for large molecule protein analysis in favor of LC-MS.
-
How Can Sponsors & CDMOs Collaborate On RNA Analytical/Process Development?
8/22/2024
Having worked on both the innovator and CDMO sides of the industry, Advancing RNA LIVE panelist Khaled Yamout outlines where he sees the greatest weaknesses in these critical sponsor-CDMO partnerships and offers guidance.
-
Using ddPCR Technology To Characterize The Poly(A) Tail Content
7/27/2023
When characterizing 3’ poly(A) tail length and integrity, Droplet Digital PCR technology demonstrates an orthogonal or alternative method to help ensure the quality and consistency of mRNA products.